Galectin Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 2.49 M | $3.21 M | 105.71% | 4.00% |
| VANGUARD GROUP INC | 02/11/2025 | 2.14 M | $2.76 M | 0.16% | 3.43% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 1.65 M | $2.13 M | 2.79% | 2.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.34 M | $1.73 M | 360.34% | 2.16% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 1.20 M | $1.55 M | 140.00% | 1.93% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.18 M | $3.25 M | 0.00% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 870,589 | $1.12 M | 0.93% | 1.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 450,200 | $580,758 | 2,767.52% | 0.72% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 422,000 | $544,380 | 100.00% | 0.68% |
| WEALTHSPIRE ADVISORS, LLC | 02/04/2025 | 398,374 | $513,903 | 0.00% | 0.64% |
| GENEOS WEALTH MANAGEMENT INC. | 01/21/2025 | 388,935 | $501,726 | 10.20% | 0.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 348,200 | $449,178 | 138.17% | 0.56% |
| ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 207,100 | $267,159 | 0.00% | 0.33% |
| 01/29/2025 | 186,014 | $213,916 | 100.00% | 0.30% | |
| RETIREMENT GUYS FORMULA LLC | 01/29/2025 | 155,343 | $200,392 | 143.42% | 0.25% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 155,000 | $199,950 | 0.00% | 0.25% |
| SOLTIS INVESTMENT ADVISORS LLC | 01/29/2025 | 140,750 | $181,568 | 0.00% | 0.23% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 134,518 | $174,000 | -72.16% | 0.22% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 118,585 | $153,000 | 3.37% | 0.19% |
| CUTTER & CO BROKERAGE, INC. | 02/04/2025 | 115,488 | $148,980 | 0.00% | 0.19% |
| LMR PARTNERS LLP | 02/14/2025 | 100,000 | $129,000 | 100.00% | 0.16% |
| JANE STREET GROUP, LLC | 02/14/2025 | 89,500 | $115,455 | 100.00% | 0.14% |
| HAP TRADING, LLC | 02/13/2025 | 75,000 | $281,250 | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 02/14/2025 | 70,100 | $90,429 | 100.00% | 0.11% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 65,073 | $83,944 | 0.00% | 0.10% |
| JPMORGAN CHASE & CO | 02/12/2025 | 59,693 | $77,004 | 94.90% | 0.10% |
| 01/31/2025 | 58,413 | $73,016 | -26.17% | 0.09% | |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 01/17/2025 | 55,670 | $71,814 | 29.85% | 0.09% |
| BARCLAYS PLC | 02/13/2025 | 54,634 | $71,000 | 91.11% | 0.09% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 02/10/2025 | 53,742 | $69,327 | 4.39% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 51,780 | $66,796 | 261.29% | 0.08% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 51,550 | $66,500 | 27.44% | 0.08% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/10/2025 | 51,369 | $141,265 | 46.36% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 50,826 | $65,565 | 18.97% | 0.08% |
| SYNOVUS FINANCIAL CORP | 02/13/2025 | 48,000 | $61,920 | 0.00% | 0.08% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 47,521 | $61,302 | 43.86% | 0.08% |
| VIVALDI CAPITAL MANAGEMENT LP | 02/14/2025 | 45,628 | $55,666 | 89.86% | 0.07% |
| WOLVERINE TRADING, LLC | 02/14/2025 | 45,100 | $49,610 | 100.00% | 0.07% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 37,884 | $48,870 | 0.00% | 0.06% |
| SOLUTIONS 4 WEALTH, LTD | 01/28/2025 | 36,003 | $46,444 | 0.00% | 0.06% |
| WOLVERINE TRADING, LLC | 02/14/2025 | 35,800 | $39,380 | 100.00% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 28,571 | $36,857 | 100.00% | 0.05% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 27,623 | $35,634 | 0.00% | 0.04% |
| MARINER, LLC | 02/13/2025 | 27,327 | $35,252 | 2.79% | 0.04% |
| GLADSTONE INSTITUTIONAL ADVISORY LLC | 01/29/2025 | 24,650 | $31,799 | 13.33% | 0.04% |
| BEACON CAPITAL MANAGEMENT, LLC | 01/30/2025 | 23,905 | $30,837 | 0.00% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 22,486 | $29,007 | 100.00% | 0.04% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 21,534 | $28,000 | 100.00% | 0.03% |
| INSPIRE ADVISORS, LLC | 02/07/2025 | 21,095 | $27,213 | 86.30% | 0.03% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 20,000 | $25,800 | 100.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Galectin Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 116 institutional investors and hedge funds held shares of Galectin Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.14 M
BlackRock Funding, Inc. /DE: 1.65 M
ADVISOR GROUP HOLDINGS, INC.: 1.18 M
GEODE CAPITAL MANAGEMENT, LLC: 870,589
Wealthspire Advisors, LLC: 398,374
Geneos Wealth Management Inc.: 388,935
16.18% of Galectin Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 12.45 M shares in the last 24 months. This purchase volume represents approximately $14.81 M in transactions.